0000950170-24-071526.txt : 20240610 0000950170-24-071526.hdr.sgml : 20240610 20240610193526 ACCESSION NUMBER: 0000950170-24-071526 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240606 FILED AS OF DATE: 20240610 DATE AS OF CHANGE: 20240610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fountain Tamara CENTRAL INDEX KEY: 0001902243 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40587 FILM NUMBER: 241034319 MAIL ADDRESS: STREET 1: C/O RXSIGHT, INC. STREET 2: 100 COLUMBIA CITY: ALISO VIEJO STATE: CA ZIP: 92656 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sight Sciences, Inc. CENTRAL INDEX KEY: 0001531177 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 800625749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4040 CAMPBELL AVE, STREET 2: SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (415) 889-0550 MAIL ADDRESS: STREET 1: 4040 CAMPBELL AVE, STREET 2: SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 ownership.xml 4 X0508 4 2024-06-06 0001531177 Sight Sciences, Inc. SGHT 0001902243 Fountain Tamara C/O SIGHT SCIENCES, INC. 4040 CAMPBELL AVE., SUITE 100 MENLO PARK CA 94025 true false false false false Common Stock 2024-06-06 4 A false 17366 0.00 A 50437 D Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $120,000 divided by the closing price of the Common Stock on the grant date, June 6, 2024. The RSUs vest on the earlier of June 6, 2025 and the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. Includes (i) 21,086 shares of Common Stock, (ii) 17,366 RSUs, which are subject to vesting as reported herein, and (iii) 11,985 RSUs granted to the Reporting Person on January 8, 2023, which are subject to vesting as previously reported. /s/ Jeremy Hayden, Attorney-in-Fact for Tamara Fountain, M.D. 2024-06-10